Trust linked to AEHR (NASDAQ: AEHR) director sells 13,998 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Aehr Test Systems director Rhea J. Posedel reported an insider sale of common stock through a trust associated with her. On February 13, 2026, the trust sold 13,998 shares of Aehr Test Systems common stock in an open-market transaction at $30.0151 per share.
After this transaction, the trust continued to hold 456,979 shares indirectly. Posedel also directly held 71,163 shares, and this direct amount includes shares subject to unvested restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 13,998 shares ($420,151)
Net Sell
2 txns
Insider
POSEDEL RHEA J
Role
Director
Sold
13,998 shs ($420K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 13,998 | $30.0151 | $420K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 456,979 shares (Indirect, By Trust);
Common Stock — 71,163 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did AEHR director Rhea J. Posedel report?
Rhea J. Posedel reported an insider sale of Aehr Test Systems common stock. A trust associated with her sold 13,998 shares on February 13, 2026, at $30.0151 per share in an open-market transaction, while retaining a significant indirect share position afterward.
Does the AEHR Form 4 mention restricted stock units held by Rhea J. Posedel?
Yes. The Form 4 states that the amount reported in Posedel’s direct holdings includes shares subject to unvested restricted stock units. This means part of her 71,163 directly held Aehr Test Systems shares comes from equity awards that will vest over time.